Pasithea Therapeutics (KTTA) Change in Cash (2021 - 2024)
Historic Change in Cash for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$2.4 million.
- Pasithea Therapeutics' Change in Cash rose 2505.5% to -$2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$9.4 million, marking a year-over-year increase of 4385.37%. This contributed to the annual value of -$9.4 million for FY2024, which is 4385.37% up from last year.
- According to the latest figures from Q4 2024, Pasithea Therapeutics' Change in Cash is -$2.4 million, which was up 2505.5% from $1.4 million recorded in Q3 2024.
- Pasithea Therapeutics' 5-year Change in Cash high stood at $32.4 million for Q4 2021, and its period low was -$9.3 million during Q4 2022.
- Over the past 4 years, Pasithea Therapeutics' median Change in Cash value was -$2.9 million (recorded in 2022), while the average stood at $421488.9.
- Per our database at Business Quant, Pasithea Therapeutics' Change in Cash tumbled by 42359.82% in 2022 and then soared by 11973.12% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Change in Cash stood at $32.4 million in 2021, then tumbled by 128.68% to -$9.3 million in 2022, then surged by 64.98% to -$3.3 million in 2023, then rose by 25.05% to -$2.4 million in 2024.
- Its last three reported values are -$2.4 million in Q4 2024, $1.4 million for Q3 2024, and -$4.0 million during Q2 2024.